Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details)

v3.7.0.1
Warrants (Details)
6 Months Ended
Jun. 30, 2017
$ / shares
shares
Warrants [Member]  
Summarizes information about warrants outstanding and exercisable  
Number of Shares Underlying Warrants Originally Granted 1,333,185
Shares Underlying Warrants Exchanged, Exercised or Expired (511,983)
Shares Underlying Warrants Outstanding and Exercisable 821,202
Series A January 27, 2014 [Member]  
Summarizes information about warrants outstanding and exercisable  
Grant Date Jan. 27, 2014 [1]
Number of Shares Underlying Warrants Originally Granted 315,676 [1]
Shares Underlying Warrants Exchanged, Exercised or Expired (315,676) [1]
Shares Underlying Warrants Outstanding and Exercisable [1]
Exercise Price | $ / shares [1]
Expiration Term in years 0 years [1]
Series B January 27, 2014 [Member]  
Summarizes information about warrants outstanding and exercisable  
Grant Date Jan. 27, 2014 [1]
Number of Shares Underlying Warrants Originally Granted 157,846 [1]
Shares Underlying Warrants Exchanged, Exercised or Expired [1]
Shares Underlying Warrants Outstanding and Exercisable 157,846 [1]
Exercise Price | $ / shares $ 45.00 [1]
Expiration Term in years 1 year 6 months 29 days [1]
Series C November 19, 2014 [Member]  
Summarizes information about warrants outstanding and exercisable  
Grant Date Nov. 19, 2014 [2]
Number of Shares Underlying Warrants Originally Granted 145,399 [2]
Shares Underlying Warrants Exchanged, Exercised or Expired (142,957) [2]
Shares Underlying Warrants Outstanding and Exercisable 2,442 [2]
Exercise Price | $ / shares $ 12.00 [2]
Expiration Term in years 2 years 10 months 17 days [2]
Series C November 19, 2014 [Member] | Revised [Member]  
Summarizes information about warrants outstanding and exercisable  
Shares Underlying Warrants Exchanged, Exercised or Expired 142,957 [2]
Shares Underlying Warrants Outstanding and Exercisable 142,957 [2]
Exercise Price | $ / shares $ 9.00 [2]
Expiration Term in years 2 years 10 months 17 days [2]
Series D November 19, 2014 [Member]  
Summarizes information about warrants outstanding and exercisable  
Grant Date Nov. 19, 2014 [2]
Number of Shares Underlying Warrants Originally Granted 193,865 [2]
Shares Underlying Warrants Exchanged, Exercised or Expired (193,865) [2]
Shares Underlying Warrants Outstanding and Exercisable [2]
Exercise Price | $ / shares [2]
Expiration Term in years 0 years [2]
Series E November 19, 2014 [Member]  
Summarizes information about warrants outstanding and exercisable  
Grant Date Nov. 19, 2014 [2]
Number of Shares Underlying Warrants Originally Granted 145,399 [2]
Shares Underlying Warrants Exchanged, Exercised or Expired (145,399) [2]
Shares Underlying Warrants Outstanding and Exercisable [2]
Exercise Price | $ / shares [2]
Expiration Term in years 0 years [2]
Series E November 19, 2014 [Member] | Revised [Member]  
Summarizes information about warrants outstanding and exercisable  
Shares Underlying Warrants Exchanged, Exercised or Expired 142,957 [2]
Shares Underlying Warrants Outstanding and Exercisable 142,957 [2]
Exercise Price | $ / shares $ 9.00 [2]
Expiration Term in years 4 years 10 months 17 days [2]
Rens March 3, 2016 [Member]  
Summarizes information about warrants outstanding and exercisable  
Grant Date Mar. 03, 2016 [3]
Number of Shares Underlying Warrants Originally Granted 375,000 [3]
Shares Underlying Warrants Exchanged, Exercised or Expired [3]
Shares Underlying Warrants Outstanding and Exercisable 375,000 [3]
Exercise Price | $ / shares $ 7.00 [3]
Expiration Term in years 3 years 8 months 2 days [3]
[1] Issued in connection with the January 27, 2014 private placement transaction.
[2] Issued in connection with the November 19, 2014 registered-direct public offering, and subsequently revised pursuant to Warrant Exercise Agreements entered into on May 18, 2015.
[3] Shares issued pursuant to the closing of the first tranche of the Financing with RENS Technology Inc.